Real-time enrollment status for this acute myeloid leukemia with complex karyotype clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 1:02 PM UTC
| NCT Number | NCT07582172 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia With Complex Karyotype |
| Phase | PHASE2 |
| Target Enrollment | 35 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of September 2, 2026: Clinical trial NCT07582172 is currently recruiting participants. This phase2 study for acute myeloid leukemia with complex karyotype is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07582172 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07582172 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.